nitrites has been researched along with Fatigue Syndrome, Chronic in 5 studies
Nitrites: Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)
Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Treatment with atorvastatin (10 and 20 mg/kg) and fluvastatin (10 mg/kg) for 21 days significantly improved the behavioral alterations [increased number of wheel rotations and locomotor activity, and anxiety like behavior (decreased number of entries and time spent in open arm)], oxidative defence and mitochondrial complex enzyme activities in brain." | 3.78 | Protective effect of HMG CoA reductase inhibitors against running wheel activity induced fatigue, anxiety like behavior, oxidative stress and mitochondrial dysfunction in mice. ( Kalonia, H; Kumar, A; Kumar, P; Mishra, J; Vashist, A, 2012) |
| "An experimental model of chronic fatigue syndrome (CFS) is utilized for evaluation of antidepressant, anti-stress effects, wherein the rat is forced to swim in water for 15 min/day on 21 consecutive days." | 1.35 | The role of antioxidant properties of Nardostachys jatamansi in alleviation of the symptoms of the chronic fatigue syndrome. ( Bhattacharyya, D; Chatterjee, S; Gomes, A; Lyle, N; Munshi, S; Paul, S; Sur, T, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thakur, V | 1 |
| Jamwal, S | 1 |
| Kumar, M | 1 |
| Rahi, V | 1 |
| Kumar, P | 3 |
| Kumar, A | 2 |
| Vashist, A | 2 |
| Kalonia, H | 1 |
| Mishra, J | 1 |
| Lyle, N | 1 |
| Gomes, A | 1 |
| Sur, T | 1 |
| Munshi, S | 1 |
| Paul, S | 1 |
| Chatterjee, S | 1 |
| Bhattacharyya, D | 1 |
| Sachdeva, AK | 1 |
| Kuhad, A | 1 |
| Tiwari, V | 1 |
| Chopra, K | 1 |
5 other studies available for nitrites and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Protective Effect of Hemin Against Experimental Chronic Fatigue Syndrome in Mice: Possible Role of Neurotransmitters.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anxiety; Behavior, Animal; Brain; Disease Models, Animal; D | 2020 |
Protective effect of HMG CoA reductase inhibitors against running wheel activity induced fatigue, anxiety like behavior, oxidative stress and mitochondrial dysfunction in mice.
Topics: Animals; Anxiety; Atorvastatin; Behavior, Animal; Brain; Catalase; Electron Transport Chain Complex | 2012 |
The role of antioxidant properties of Nardostachys jatamansi in alleviation of the symptoms of the chronic fatigue syndrome.
Topics: Animals; Antioxidants; Anxiety; Brain; Catalase; Disease Models, Animal; Fatigue Syndrome, Chronic; | 2009 |
Epigallocatechin gallate ameliorates chronic fatigue syndrome in mice: behavioral and biochemical evidence.
Topics: Animals; Antioxidants; Brucella abortus; Catalase; Catechin; Disease Models, Animal; Fatigue Syndrom | 2009 |
Potential role of pioglitazone, caffeic acid and their combination against fatigue syndrome-induced behavioural, biochemical and mitochondrial alterations in mice.
Topics: Animals; Antioxidants; Behavior, Animal; Caffeic Acids; Catalase; Drug Synergism; Drug Therapy, Comb | 2010 |